MAP3K14 and alkaline phosphatase measurement: A significant difference in hs-CRP levels was observed between patients with CAD with AP [1.95 (0.13-6.34) (2.17)] and controls [1.04 (0.40-3.12) (1.30)] mg/L at baseline.